Literature DB >> 10330158

Identification of Id2 as a globin regulatory protein by representational difference analysis of K562 cells induced to express gamma-globin with a fungal compound.

M L Holmes1, J D Haley, L Cerruti, W L Zhou, H Zogos, D E Smith, J M Cunningham, S M Jane.   

Abstract

A fungus-derived compound (OSI-2040) which induces fetal globin expression in the absence of erythroid cell differentiation was identified in a high-throughput drug discovery program. We utilized this compound to isolate gamma-globin regulatory genes that are differentially expressed in OSI-2040-induced and uninduced cells in the human erythroleukemia cell line K562. Representational difference analysis (RDA) of cDNA revealed several genes that were significantly up- or down-regulated in OSI-2040-induced cells. One gene whose expression was markedly enhanced was the gene for the helix-loop-helix (HLH) transcription factor Id2. Southern analysis of RDA amplicons demonstrated progressive enrichment of Id2 with each successive subtraction of uninduced cDNA from induced cDNA. Northern analysis of OSI-2040-induced K562 cells confirmed that Id2 expression was directly up-regulated coordinately with gamma-globin. Analysis of other inducers of fetal globin demonstrated up-regulation of Id2 with sodium butyrate but not with hemin. Retrovirus-mediated overexpression of Id2 in K562 cells reproduced the enhancement of endogenous globin expression observed with OSI-2040 induction. Functional assays demonstrated that an E-box element in hypersensitivity site 2 is required for Id2-dependent enhancement of gamma-promoter activity. Protein binding studies suggest that alterations in E-box site occupancy by basic HLH proteins may influence this activity, thus expanding the potential role of these factors in globin gene regulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330158      PMCID: PMC104377          DOI: 10.1128/MCB.19.6.4182

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Inhibition of myeloid differentiation by the helix-loop-helix protein Id.

Authors:  B L Kreider; R Benezra; G Rovera; T Kadesch
Journal:  Science       Date:  1992-03-27       Impact factor: 47.728

2.  Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins.

Authors:  X H Sun; N G Copeland; N A Jenkins; D Baltimore
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

3.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence.

Authors:  C Murre; P S McCaw; H Vaessin; M Caudy; L Y Jan; Y N Jan; C V Cabrera; J N Buskin; S D Hauschka; A B Lassar
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

4.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.

Authors:  C Murre; P S McCaw; D Baltimore
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

Review 5.  Levels of fetal hemoglobin necessary for treatment of sickle cell disease.

Authors:  C T Noguchi; G P Rodgers; G Serjeant; A N Schechter
Journal:  N Engl J Med       Date:  1988-01-14       Impact factor: 91.245

6.  Cloning the differences between two complex genomes.

Authors:  N Lisitsyn; N Lisitsyn; M Wigler
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

7.  Sodium butyrate inhibits histone deacetylation in cultured cells.

Authors:  E P Candido; R Reeves; J R Davie
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

Review 8.  Globin gene expression in hereditary persistence of fetal haemoglobin and (delta beta) (0)-thalassaemia.

Authors:  M Poncz; P Henthorn; C Stoeckert; S Surrey
Journal:  Oxf Surv Eukaryot Genes       Date:  1988

9.  Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and beta-thalassemia.

Authors:  E Fibach; P Prasanna; G P Rodgers; D Samid
Journal:  Blood       Date:  1993-10-01       Impact factor: 22.113

10.  Identification of a stage selector element in the human gamma-globin gene promoter that fosters preferential interaction with the 5' HS2 enhancer when in competition with the beta-promoter.

Authors:  S M Jane; P A Ney; E F Vanin; D L Gumucio; A W Nienhuis
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

View more
  5 in total

1.  Induction of human fetal globin gene expression by a novel erythroid factor, NF-E4.

Authors:  W Zhou; D R Clouston; X Wang; L Cerruti; J M Cunningham; S M Jane
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

Review 2.  Regulation of human fetal hemoglobin: new players, new complexities.

Authors:  Arthur Bank
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

3.  Cytokine-mediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming.

Authors:  Orapan Sripichai; Christine M Kiefer; Natarajan V Bhanu; Toshihiko Tanno; Seung-Jae Noh; Sung-Ho Goh; J Eric Russell; Cheryl L Rognerud; Ching-Nan Ou; Patricia A Oneal; Emily R Meier; Nicole M Gantt; Colleen Byrnes; Y Terry Lee; Ann Dean; Jeffery L Miller
Journal:  Blood       Date:  2009-07-13       Impact factor: 22.113

4.  Identification and characterization of mechanistically distinct inducers of gamma-globin transcription.

Authors:  John D Haley; David E Smith; Janine Schwedes; Richard Brennan; Cedric Pearce; Claudia Moore; Faye Wang; Fillipo Petti; Frank Grosveld; Stephen M Jane; Constance T Noguchi; Alan N Schechter
Journal:  Biochem Pharmacol       Date:  2003-11-01       Impact factor: 5.858

5.  Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1.

Authors:  Amanda J Grieco; Henny H Billett; Nancy S Green; M Catherine Driscoll; Eric E Bouhassira
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.